Ad Soyad:
Bülent Akdoğan
Ünvanı:
Prof.Dr.
Bölüm:
Üroloji
İletişim:
(312) 305 19 70
Dr Akdoğan (Ankara/Türkiye), Üroloji Profesörüdür. Hacettepe Üniversitesi İngilizce Tıp Fakültesi'nden 1997 yılında mezun olarak Tıp Doktoru ve yine Hacettepe Üniversitesi Tıp Fakültesi Üroloji Anabilim Dalı'nda asistanlığını tamamlayarak 2003 yılında Üroloji Uzmanı ünvanını almıştır.
2004-2006 yılları arasında Hacettepe'de Üroonkoloji konusunda klinik fellow, 2006 yılında Harward University, Brigham and Women's Hospital and Dana Farber Cancer Institute'de, 2009 yılında ise Avrupa Üroloji Derneği (EAU) EUSP Bursu kazanarak Leuven Catholic Hospital'de klinik fellow olarak çalışmıştır.
Lise birinciliği yanında, Ankara Ürologlar Derneği asistan değerlendirme sınavında birincilik (2001),European Board of Urology (EBU) In-Service Examination 76 asistan arasında birincilik (2002),EBU In-Service Examination, 122 asistan arasında birincilik (2003),14th European Society for Paediatric Urology (ESPU) ve 18th European Association of Urology (EAU) Kongresi, Klinik Poster 3.’lük ödülü (Madrid, 2003) ve1. Tıbbi Onkoloji Kongresi, Sözlü Poster 3.’lüködülleri almıştır (2006).
Ürolojik kanserlerin tıbbi ve cerrahi tedavisi konusu özel ilgi alanıdır.
Üroonkoloji Derneği prostat kanseri çalışma grubu üyesi, Üroonkoloji Bülteni yardımcı editörüdür. Avrupa Üroloji Derneği YAU böbrek kanseri çalışma grubu üyesi, EAU hasta bilgilendirme formlarını hazırlayan akademisyenlerden birisidir. Hacettepe Üniversitesi Tıp Fakültesi Fakülte Kurulu ve Yönetim Kurulu üyesidir.
PUBLICATIONS
-
- Dogan HS, Sahin A, Cetinkaya Y, Akdogan B, Ozden E, Kendi S. Antibiotic prophylaxis in percutaneous nephrolithotomy: prospective study in 81 patients. J Endourol. 2002, Nov;16(9):649-53.
- Dogan HS, Tekgul S, Akdogan B, Keskin MS, Sahin A. Use of the holmium:YAG laser for ureterolithotripsy in children. BJU Int. 2004, Jul;94(1):131-3.
- Dogan HS, Eskicorapci SY, Ertoy-Baydar D, Akdogan B, Gunay LM, Ozen H. Can we obtain better specimens with an end-cutting prostatic biopsy device? Eur Urol. 2005, Mar;47(3):297 301.
- Eskicorapci SY, Guliyev F, Akdogan B, Dogan HS, Ergen A, Ozen H. Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection. J Urol. 2005, May;173(5):1536-40.
- Eskicorapci SY, Guliyev F, Akdogan B, Dogan HS, Ergen A, Ozen H. Re: Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection. J Urol. 2005, Nov;174: 2067-71.
- Naghizadeh S, Kefi A, Dogan HS, Burgu B, Akdogan B, Tekgul S. Effectiveness of oral desmopressin therapy in posterior urethral valve patients with polyuria and detection of factors affecting the therapy. Eur Urol. 2005, Nov;48(5):819-25.
- Akpinar E, Turkbey B, Ozcan O, Akdogan B, Karcaaltincaba M, Ozen H. Bilateral scrotal extraperitoneal herniation of ureters: computed tomography urographic findings and review of the literature. J Comput Assist Tomogr. 2005, Nov-Dec;29(6):790-2.
- Eskicorapci SY, Ozkara HA, Onder E, Akdogan B, Erkan I, Ciliv G, Ozen H. Serum ribonuclease activity in the diagnosis of prostate cancer in men with serum prostate-specific antigen levels between 2.5 and 20 ng/mL. Clin Biochem. 2006, Apr;39(4):363-6.
-
- Akdogan B, Dogan HS, Eskicorapci SY, Sahin A, Erkan I, Ozen H. Prognostic significance of bladder tumor history and tumor location in upper tract transitional cell carcinoma. J Urol. 2006, Jul;176(1):48-52.
- Akyol F, Selek U, Ozyigit G, Onal C, Akdogan B, Karabulut E, Ozen H. Preliminary results of bicalutamide monotherapy on biochemical failure of localized prostate cancer. J Natl Med Assoc. 2006, Jul;98(7):1058-61.
11. Akdogan B, Dogan HS, Keskin S, Burgu B, Tekgul S. Significance of age specific creatinine levels at presentation in posterior urethral valve patients. J Ped Urol. 2006, 2: 446-452.
-
- Ersoy O, Aran R, Aydinli M, Yonem O, Harmanci O, Akdogan B, Pinar A, Sokmensuer C, Bayraktar Y. Granulomatous hepatitis after intravesical BCG treatment for bladder cancer. Indian J Gastroenterol. 2006, Sep-Oct;25(5):258-9.
- Divrik RT, Akdogan B, Ozen H, Zorlu F. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumors-is shift to risk adapted policy justified? J Urol. 2006, Oct;176(4):1424-30.
-
- Baydar DE, Kosemehmetoglu K, Akdogan B, Ozen H. Prostatic adenosquamous carcinoma metastasizing to testis. ScientificWorld Journal. 2006 Oct 2;6:2491-4.
- Akdogan B, Divrik RT, Tombul T, Yazici S, Tasar C, Zorlu F, Ozen H. Bilateral testicular germ cell tumors in Turkey: increase in incidence in last decade and evaluation of risk factors in 30 patients. J Urol. 2007 Jul;178(1):129-33; discussion 133.
- Akdogan B, Divrik RT, Tombul T, Yazici S, Tasar C, Zorlu F, Ozen H. Re: Bilateral testicular germ cell tumors in Turkey: increase in incidence in last decade and evaluation of risk factors in 30 patients. J Urol. 2007 Nov;178:2222-24.
- Inci K, Dogan HS, Akdogan B, Ergen A, Tasar C, Ozen H. Does age affect the prognosis of patients with testicular germ cell tumor? Urol Int. 2007;79(2):117-23.
- Aksoy S, Harputluoglu H, Kilickap S, Dincer M, Dizdar O, Akdogan B, Ozen H, Erman M, Celik I. Erectile dysfunction in successfully treated lymphoma patients. Support Care Cancer. 2008 Mar;16(3):291-7.
- Yazici S, Inci K, Bilen CY, Gudeloglu A, Akdogan B, Ertoy D, Kaynaroglu V, Demircin M, Ozen H. Renal cell carcinoma with inferior vena cava thrombus: the Hacettepe experience. Urol Oncol. 2010;28(6):603-9.
- Inci K, Dogan HS, Akdogan B, Baydar DE, Ergen A, Ozen H. Presence of teratoma in orchiectomy specimen increases the need for postchemotherapy RPLND. Urol Oncol. 2009 Mar 6. [Epub ahead of print]
- Ulu B, Tüzel E, Aktepe F, Akdogan B, Güler C. Evaluation of shockwave lithotripsy induced renal damage using heat shock protein 70 expression in the presence of different urinary obstruction periods. J Endourol. 2009 Jul;23(7):1093-8.
- Baseskioglu B, Akdogan B, Baydar DE, Ozen H. Can p53, Ki-67 and bcl-2 predict biochemical failure after radical prostatectomy? Indian J Urol. 2010 Apr;26(2):206-12.
- Akdogan B, Gudeloglu A, Inci K, Gunay LM, Koni A, Ozen H. Prevalence and Predictors of Benign Lesions in Renal Masses Smaller Than 7 cm Presumed to be Renal Cell Carcinoma. Clin Genitourin Cancer. 2012 Jun;10(2):121-5.
- Guner G, Akdogan B, Baydar DE. Malakoplakia of prostate as a complication of transrectal needle biopsy. Can J Urol. 2012 Feb;19(1):6124-7.
- Divrik RT, Türkeri L, Şahin AF, Akdoğan B, Ateş F, Çal Ç, Baltacı S; Urooncology Association. Prediction of response to androgen deprivation therapy and castration resistance in primary metastatic prostate cancer. Urol Int. 2012;88(1):25-33. Epub 2011 Dec 17.
- Aslan G, Baltaci S, Akdogan B, Kuyumcuoğlu UG, Kaplan M, Cal C, Adsan O, Turkolmez K, Ugurlu O, Ekici S, Faydaci G, Mammadov E, Turkeri L, Ozen H, Beduk Y. A prospective randomized multicenter study of Turkish Society of Urooncology comparing two different mechanical bowel preparation methods for radical cystectomy. Urol Oncol. 2011 May 3. [Epub ahead of print].
- Tuzel E, Aktepe OC, Akdogan B. Prospective comparative study of two protocols of antibiotic prophylaxis in percutaneous nephrolithotomy. J Endourol. 2013 Feb;27(2):172-6.
- Salagierski M, Akdogan B, Brookman-May S, Dobrowolska-Glazar B, Ficarra V, Langenhuijsen JF, Marszalek M, Minervini A, Rodriguez-Faba O, Roscigno M, Vandromme A, Volpe A, Joniau S; Renal Cancer Working Group of the Young Academic Urologists Working Party of the European Association of Urology. What is the contemporary role of radiofrequency ablation in the management of small renal masses? Are small lesions the radiologist's tumors? Eur Urol. 2013 Mar;63(3):493-5.
- Gunay LM, Akdogan B, Koni A, Inci K, Bilen CY, Ozen H. Upper urinary tract transitional cell carcinoma: is there a best? Clin Genitourin Cancer. 2013 Mar;11(1):39-44.
- Brookman-May S, Minervini A, Volpe A, Ficarra V, Salagierski M, Marszalek M, Roscigno M, Akdogan B, Vandromme A, Langenhuijsen JF, Rodriguez-Faba O, Joniau S; Renal Cancer Working Group of the Young Academic Urologists (YAU) Working Party of the European Association of Urology (EAU). Robot-assisted partial nephrectomy in patients with recurrent disease: fiction or fact? BJU Int. 2013 May;111(5):692-4.
- Brookman-May S, Langenhuijsen JF, Volpe A, Minervini A, Joniau S, Salagierski M, Roscigno M, Akdogan B, Vandromme A, Rodriguez-Faba O, Marszalek M. Management of localized and locally advanced renal tumors. A contemporary review of current treatment options. Minerva Med. 2013 Jun;104(3):237-59. Review.
- Abdullazade S, Kara O, Akdoğan B, Baydar DE. Primary low grade intratesticular leiomyosarcoma: case report and review of the literature. Turk Patoloji Derg. 2013;29(3):227-30.
PPresentations at the International Congresses
1. Ozden E, Tekgul S, Oner S, Atsu N, Akdogan B, Ergen A, Kendi S. Symptom scoring in the evaluation of voiding dysfunction in children. Eur Urol.39 (supp 5):705-2001 16th Congress of European Association of Urology, Geneva, April 7-10, 2001, Geneva.
2. Erdil E, Akdogan B, Halicigil C, Aksu T and Yarali H. Prior diagnostic testicle biopsy cannot highly predict the success or failure of retrieval of sperm at testicular sperm extraction. Human Reproduction 17:105-2002. 18. Annual meeting of European Society of Human Reproduction and Embryology, July 1-3 2002, Vienna.
3. Dogan HS, Sahin A, Cetinkaya Y, Akdogan B, Ozden E, Kendi S. Antibiotic Prophylaxis in Percutaneous Nephrolithotomy: A Prospective Study in 81 Patients. 20th World Congress on Endourology and SWL, 18.Basic Research Symposium, September 19-22, 2002, Genoa.
4. Akdogan B, Gunay M, Inci K, Guliyev F, Sahin A, Tekgul S. Metabolic Evaluation in childhood stone disease. 14th ESPU Congress, March 12-15, 2003, Madrid.
5. Akdogan B, Gunay M, Inci K, Bakkaloglu M, Sahin A, Tekgul S. The Hacettepe Experience in paediatric stone disease. 14th ESPU Congress, March 12-15, 2003, Madrid.
6. Akdogan B, Gunay M, Keskin S, Oner S, Tekgul S. Outcome of patients with PUV diagnosed and treated later in life. 14th ESPU Congress, March 12-15, 2003, Madrid.
7. Akdogan B, Gunay M, Inci K, Sahin A, Tekgul S. Metabolic Evaluation in childhood stone disease. 98th AUA Congress, April 26-May 1, 2003, Chicago.
8. Sofikerim M, Akdogan B, Keskin S, Dogan HS, Erkan İ, Kendi S, Sahin A. Percutaneous Nephrolithotomy in patients aged 60 years or older. 2nd EULIS Symposium (10th European Symposium on Urolithiazis), June 11-14, 2003, Istanbul.
9. Dogan HS, Cetinkaya Y, Guliyev F, Akdogan B, Inci K, Ergen A, Sahin A. Infection in patients who underwent percutaneous nephrolithotomy. 2nd EULIS Symposium (10th European Symposium on Urolithiazis), June 11-14, 2003, Istanbul.
10. Akdogan B, Guliyev F, Gunay M, Inci K, Akbal C, Sahin A, Tekgul S. Metabolic evaluation in pediatric stone disease. 2nd EULIS Symposium (10th European Symposium on Urolithiazis), June 11-14, 2003, Istanbul.
11. Akdogan B, Gunay M, Inci K, Sofikerim M, Burgu B, Sahin A, Tekgul S. Hacettepe experience in pediatric stone disease. 2nd EULIS Symposium (10th European Symposium on Urolithiazis), June 11-14, 2003, Istanbul.
12. Tekin A, Atsu N, Akdogan B, Sofikerim M, Sahin A, Tekgul S. Cystine calculi in children: The results of a metabolic evaluation and response to medical therapy. 2nd EULIS Symposium (10th European Symposium on Urolithiazis), June 11-14, 2003, Istanbul.
13. Dogan HS, Tekgul S, Keskin S, Akdogan B, Baseskioglu B, Sahin A. Our experience on endoscopic surgery for ureteral calculi in pediatric population. 2nd EULIS Symposium (10th European Symposium on Urolithiazis), June 11-14, 2003, Istanbul.
14. Tekin A, Atsu N, Akdogan B, Dogan S, Sahin A, Bakkaloglu M, Tekgul S. Oral potassium citrate replacement therapy for the prevention of recurrence of calcium urolithiazis in children with hypocitraturia. 2nd EULIS Symposium (10th European Symposium on Urolithiazis), June 11-14, 2003, Istanbul.
15. Tekgul S, Gunay M, Akdogan B, Guliyev F, Bakkaloglu M, Kendi S. Paediatric stone disease and vesicoureteral reflux. 19th EAU Congress, Vienna, March 24-27, 2004.
16. Akdogan B, Guliyev F, Gunay M, Inci K, Sahin A, Tekgul S. Demographic and clinical features of paediatric stone disease. 19th EAU Congress, Vienna, March 24-27, 2004.
17. Eskicorabcı S, Gunay M, Islamoglu E, Akdogan B, Ergen A, Ozen H. Results of the 14 core prostate biopsy for the repeat biopsy population. 19th EAU Congress, Vienna, March 24-27, 2004.
18. Dogan S, Tekgul S, Keskin S, Akdogan B, Baseskioglu B, Sahin A. Our experience on endoscopic surgery for ureteral calculi in pediatric population. 19th EAU Congress, Vienna, March 24-27, 2004.
19. Tekgul S, Akdogan B, Dogan S, Keskin S, Gunay M, Burgu B, Sahin A, Erkan İ, Kendi S. Factors affecting prognosis in patients with posterior urethral valve. 19th EAU Congress, Vienna, March 24-27, 2004.
20. Gunay L, Akdogan B, Guliyev F, Inci K, Tekgul S. How frequent is vesicoureteral reflux (VUR) in children with stone disease? 20th EAU Congress, Istanbul, March 16-19, 2005.
21. Akdogan B, Dogan I, Dogan S, Guliyev F, Ekici S, Ozen H. Significance of early detection in collecting duct carcinoma of kidney: clinicopathological study of 4 cases. 20th EAU Congress, Istanbul, March 16-19, 2005.
22. Akdogan B, Dogan S, Eskicorapci S, Tan B, Erkan I, Ozen H. Incidental diagnosis in renal cell carcinoma: does it have a prognostic importance? 20th EAU Congress, Istanbul, March 16-19, 2005.
23. Akdogan B, Dogan S, Inci K, Eskicorapci S, Ozcan O, Ozen H. Do benign renal pathologies cause organ loss? 20th EAU Congress, Istanbul, March 16-19, 2005.
24. Akdogan B, Dogan S, Keskin S, Tekgul S. Significance of age specific creatinine levels in posterior urethral valve (PUV) patients. 20th EAU Congress, Istanbul, March 16-19, 2005.
25. Eskicorapci SY, Guliyev F, Akdogan B, Dogan HS, Ergen A, Ozen H. Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection. 20th EAU Congress, Istanbul, March 16-19, 2005.
26. Dogan HS, Tekgul S, Akdogan B, Keskin S, Baseskioglu B, Sahin A. Ho:YAG Laser ureterolithotripsy for distal ureteral stones in children. 20th EAU Congress, Istanbul, March 16-19, 2005.
27. Kefi A, Dogan S, Akdogan B, Burgu B, Naghizadeh S, Tekgul S. Efficacy of ddavp treatment in posterior urethral valve patients with polyuria. ESPU-AAP Meeting, J Pediatric Urol. 1(3) 159-160, June, 2005.
28. Akdogan B, Dogan HS, Guliyev F, Gunay M, Sahin A and Tekgul S. Role of ESWL in the management of cystine calculi in children: is it not any effective? 17th ESPU Congress, Athens, April, 2006.
29. Divrik R, Akdogan B, Ozen H, Zorlu F. Outcomes of surveillance protocol of clinical stage I nonseminomatous germ cell tumours; is shift to risk adapted policy justified? 21st Congress of EAU, Paris, April 5-8, 2006.
30. Akdogan B, Divrik T, Dogan S, Tombul T, Zorlu F, Tasar C, Ozen H. Bilateral testicular germ cell tumours in Turkey: Long term results and risk factors in 27 patients. 21st Congress of EAU, Paris, April 5-8, 2006.
31. Guler C, Aktepe F, Tuzel E, Dilek H, Küçüker H, Akdoğan B, Uzun I, Polat K. Latent carcinoma of the prostate in Turkey: an autopsy study. 28th Congress of the Societe Internationale d’Urologie, Cape Town, November 12-16, 2006.
32. Ulu B, Tuzel E, Akdogan B, Aktepe F, Kara T, Demirbaş M, Guler C. Evaluation of shock wave lithotripsy induced renal damage using heat shock protein 70 expression in the presence of different urinary obstruction periods. 23rd Congress of EAU, Milan, 26-29 March, 2008.
33. Akdogan B, Ozen H, Kirdal Y. Is intermittent docetaxel chemotherapy reasonable in hormone refractory prostate cancer? A pilot randomized study. 23rd Congress of EAU, Milan, 26-29 March, 2008.
34. Tuzel E, Aktepe OC, Akdogan B. Prospective compatative study of two protocols of antibiotic prophylaxis in patients undergoing percutaneous nephrolithotomy. 24th Annual European Association of Urology Congress. Eur Urol. Suppl 8(4):263. Stockholm, Sweden, March 17-21 2009.
35. Tuzel E, Kiziltepe G, Akdogan A. The effect of local anesthetic infiltration around nephrostomy tract on postoperative pain control after percutaneous nephrolithotomy. 24th Annual European Association of Urology Congress 8(4):325, Stockholm, Sweden, March 17-21, 2009.
36. Akdogan B, Yazici S, Kirdal Y, Inci K, Erman M, Ozen H. 104th AUA Congress konferansı dahilinde "JOURNAL OF UROLOGY" bildiri kitapçığındaki "Is intermittent docetaxel chemotherapy reasonable in hormone refractory prostate cancer? A pilot randomized study.", 181(4):233 pp., Chicago, USA, April 25-30, 2009.
37. Akdogan B, Gunay M, Kirdal Y, Inci K, Ergen A, Ozen H. Survival analysis in 83 docetaxel treated prostate cancer patients, does PSA mean anything. 9th International Prostate Forum 2009; 90, İzmir, Turkey, October 8-10, 2009.
38. Gunay M, Akdogan B, Koni A, Dikmen AV, Bilen CY, Ozen H. Demographic and clinical features in upper urinary tract transitional cell carcinoma series; what have we learned in 22 years? 5th Internationale Asian Pacific Organization for Cancer Prevention (APOCP) Conference. 0-125: 610, Istanbul, Turkey, April 3-7, 2010.
39. Akdogan B, Gunay M, Tahir Y, Kirdal Y, Kara O, Ozen H. Mitoxantrone in docetaxel resistant prostate cancer, is it a feasible alternative? 5th Internationale Asian Pacific Organization for Cancer Prevention (APOCP) Conference. O-124: 559, Istanbul, Turkey, April 3-7, 2010.
40. Joniau S, Gontero P, Briganti A, Marchioro G, Akdogan B, Hsu CY, Vander Eeckt K, Bader P, Kneitz B, Walz J, Frohneberg D, Graefen M, Montorsi F, Tizzani A, Tombal B, Van Cangh P,Van Poppel H, Spahn M. Value of extended lymph node dissection in node positive high-risk localized prostate cancer is uncertain. 25th Congress of European Association of Urology. Eur Urol Suppl. 9(2):265. Barcelona, Spain, April 16-20, 2010.
Üroonkoloji: Böbrek, Mesane, Prostat ve Testis Kanserleri ve Benign Prostat Hiperplazisi
| Lise |
|
|||||||||
| Lisans |
|
|||||||||
| Yüksek Öğrenim |
|
|||||||||
| Yurtdışı Deneyim / Eğitim | Klinik Fellow: St Radboud, Universitair Medisch Centrum Pediatric Urology Center (F.J. Feitz Wouter) Nijmegen, The Netherlands, March 2004 Clinic Observer: Harward University, Brigham and Women’s Hospital and Dana Farber Cancer Institute (Prof. Dr. Jerome Paul Richie) Boston, Massachusetts, USA August 2005. Clinic Fellow: Leuven Catholic Hospital (Prof. Dr. Hendrik van Poppel) Leuven, Belgium January-April 2009 | |||||||||
| Yabancı Dil | İngilizce |
: (312) 305 19 70
: blntakdogan@yahoo.com
: facebook.com/Bulent Akdogan